ADEL Inc., a biopharma company, has entered into an exclusive worldwide license agreement with Sanofi for the development and ...

Lindus Health and Quotient Sciences have partnered to enable enhanced patient recruitment for Phase I-IIa clinical studies ...

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production, and commercialization of ...

Grifols S.A. has received certification from the European Medicines Agency (EMA) for the entire value chain of Grifols Egypt ...

Thermo Fisher Scientific Inc. has introduced Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X).

Dren Bio, a privately held, clinical-stage biotechnology company, has entered a strategic collaboration with Sanofi for the discovery and development of a next-generation B-cell depleting therapy to ...

Gaelic Laboratories, a manufacturer of Beta-Lactam products, has acquired Athlone Laboratories, a developer and manufacturer ...

SOBI has agreed to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly potent and ...

Zealand Pharma A/S and OTR Therapeutics have entered into a strategic collaboration and license agreement aimed at ...

Eli Lilly and Company plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama.

As drug development grows increasingly complex, pharma and biotech teams are seeking partners with the scientific depth and ...

Vetter, a globally leading CDMO, announces the retirement of its Managing Director Thomas Otto after more than 35 years at the company. He will step down at the end of 2025.